Delisting risk
VTAK · AMEX · Medical - Devices

Catheter Precision (VTAK)

VIVO cardiac-mapping devices and FLYTE private aviation services.

$0.1970
Pre-market−0.00 (−0.66%)
At close$0.1983(0.00%)

In millions of USD, except per-share figures

In millionsQ4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue00000000001
Cost of revenue00000000001
Gross profit00000000000
33333433334
Research & development00000000000
Selling, general & administrative33333333334
Operating income−3−3−3−3−3−3−3−3−3−2−4
20−2−11−1−41−300
Interest income00000000000
Interest expense00000000000
Other non-operating income−2011−114−130−1
Income before tax−1−3−4−4−2−5−6−2−6−2−4
Income tax expense00003−1−10000
Net income from continuing operations−1−3−4−4−6−4−5−2−6−2−4
Discontinued operations00000000000
Other adjustments00000000100
Net income−1−3−4−4−6−4−5−2−5−2−4
EPS, basic−$0.10−$0.36−$5.57−$2.01−$1.35−$0.36−$0.38−$1.70−$3.32−$1.39−$0.92
EPS, diluted−$0.10−$0.36−$5.57−$2.01−$1.35−$0.36−$0.38−$1.70−$3.32−$1.39−$0.92
Weighted average shares, basic771281113131,0812,1922,767
Weighted average shares, diluted771281113131,0812,1922,767
EBITDA0−2−4−4−2−4−6−2−5−2−3
Depreciation & amortization11111111100
EBIT−1−3−4−4−2−5−6−2−6−2−3